Lilly's Latest Olumiant Data Raise Question Of JAK Inhibitor Role In Atopic Dermatitis

 
• By Mandy Jackson

While the BREEZE-AD7 data show that baricitinib may effectively treat AD in combination with topical corticosteroids, a patient treated with the drug in the ex-US study had a pulmonary embolism.

Doctor consulting with patient presenting results on x-ray film About the problem of the patient - Image
A pulmonary embolism was reported with Olumiant in a new study. • Source: Shutterstock

More from Clinical Trials

More from R&D